Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease
Authors:
- Kimon StamatelopoulosKSKimon Stamatelopoulos
- Christine J. PolCPChristine J. Pol
- Colby AyersCAColby Ayers
- Georgios GeorgiopoulosGGGeorgios Georgiopoulos
- Aikaterini GatsiouAikaterini Gatsiou
- Emmanouil S. BrilakisEBEmmanouil S. Brilakis
- Amit KheraAKAmit Khera
- Konstantinos DrosatosKDKonstantinos Drosatos
- James A. de LemosJLJames A. de Lemos
- Konstantinos StellosKSKonstantinos Stellos
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Amyloid-β (1-40) and Mortality in Patients With Non–ST-Segment Elevation Acute Coronary SyndromeAnnals of Internal Medicine, 2018
- Amiloide beta (1-40) en sangre, cognición y pronóstico en insuficiencia cardiacaRevista Espanola de Cardiologia, 2017
- Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart FailureRevista Española de Cardiología (English Edition), 2017
- Sedentary Behavior and Subclinical Cardiac InjuryCirculation, 2017
- Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer’s DiseaseJACC, 2016
- Amyloid-Beta (1-40) and the Risk of Death From Cardiovascular Causes in Patients With Coronary Heart DiseaseJACC, 2015